Dominique Genre is an expert in Oncology at Institut Paoli-Calmettes (France). As of April 2026, ScienceLeadR ranks Dominique Genre in the top 1% of experts in France for Hematologic Neoplasms. Dominique Genre has authored 49 publications, the most recent in 2019, and is an investigator in 69 clinical trials, 13 of them ongoing. SLR score: 1,139 (community average: 125). How the SLR is computed.

LeadR Profile

Dominique Genre Institut Paoli-Calmettes France
1 139 ScienceLeadR Reputation 1139
Network Map

Oncology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1997 - 2019

Source: PubMed

Institute Paoli-Calmettes

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 49

Citations

Citations: 1 075 1st author: 7 Last author: 3 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer.
PMID 31064127 — drug therapy, stem cells, breast neoplasms, microscopy, electron, scanning transmission, disease-free survival, bevacizumab, chemotherapy
J Clin Med20198
Marketing Authorization Procedures for Advanced Cancer Drugs: Exploring the Views of Patients, Oncologists, Healthcare Decision Makers, and Citizens in France.
PMID 28199180 — decision making, pharmaceutical preparations, therapeutics, neoplasms, disease-free survival, marketing, oncologists, progression-free survival
Med Decis Making20176
A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design.
PMID 28399840 — length of stay, morbidity, rectal neoplasms, disease-free survival, case-control studies, quality of life, proctectomy
BMC Cancer2017110
Mo1237 Percutaneous Biliary Drainage Versus EUS Guided Biliary Drainage: A Multicenter Randomized Phase II Study
OpenAlex W2607888692 — drainage
Gastrointest Endosc20172
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer.
PMID 22771827 — therapeutics, pancreatic neoplasms, disease-free survival, sorafenib, progression-free survival
Ann Oncol2012212

Clinical Studies 69

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 60
Phase 2 4
Phase 1 3
Phase 3 2

By status:

Recruiting 30
Unknown 29
Not yet recruiting 8
Completed 2

By type:

Interventional 38
Observational 31

By Monocentric/Multicentric:

monocentric 59
multicentric2to4 8
multicentric5to9 1
multicentricup10 1

Main Topics

Ongoing Clinical Trials

13 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas
NCT06000553 — pancreatic neoplasms, blood, neoplasms, pathology, biopsy, pancreas, edetic acid
N/ANot yet recruiting2023
Test of CD47 SIRP Inhibitors on the Immune Microenvironment Colon Cancer
NCT05955196 — blood, neoplasms, colon, tissues, colonic neoplasms, small molecules
N/ARecruiting2023
PANCREATIC CANCER DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT
NCT05802485 — radiotherapy, exercise, pancreatic neoplasms, operating rooms, blood, induction chemotherapy, neoplasms, biopsy, drug therapy, therapeutics, chemotherapy
N/ANot yet recruiting2023
Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance
NCT05602168 — bone marrow, blood, hematologic neoplasms, neoplasms, leukemia, therapeutics
N/ANot yet recruiting2023
Evaluation of the Impact of Sports inspired Onco coaching on Health related Quality s Life of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells
NCT05486273 — cells, quality of life, microscopy, electron, scanning transmission, hematologic neoplasms, neoplasms, transplantation, homologous, stem cells, respiratory aspiration, mentoring, transplants, hematopoietic stem cells, transplantation, sports
N/ANot yet recruiting2023

LeadR Networks

Main global connection map